cefuroxime has been researched along with Erysipelas in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Erysipelas: An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Erysipelas is a bacterial infection of the dermis and hypodermis, mostly of streptococcal origin." | 5.33 | Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance. ( Georgala, S; Krasagakis, K; Maniatakis, P; Samonis, G; Tosca, A, 2006) |
| "Erysipelas is a bacterial infection of the dermis and hypodermis, mostly of streptococcal origin." | 1.33 | Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance. ( Georgala, S; Krasagakis, K; Maniatakis, P; Samonis, G; Tosca, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krasagakis, K | 1 |
| Samonis, G | 1 |
| Maniatakis, P | 1 |
| Georgala, S | 1 |
| Tosca, A | 1 |
1 other study available for cefuroxime and Erysipelas
| Article | Year |
|---|---|
Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefuroxime; Cloxacillin; Drug Therapy, Combination; Erysipelas; | 2006 |